Publication | Closed Access

Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancer

NanoparticlesNanomedicineBreast OncologyEngineeringProtein NanoparticlesTherapeutic NanomaterialsBreast CancerTumor TargetingBiomedical EngineeringMedicineRadiation OncologyEnhanced Anti-tumor EffectsTumor BiologyBiomolecular EngineeringHer2-positive Breast Cancer